MDCO » Topics » Item 7.01. Regulation FD Disclosure.

This excerpt taken from the MDCO 8-K filed Sep 11, 2007.

Item 7.01.  Regulation FD Disclosure.

The Medicines Company (the “Company”) filed a Current Report on Form 8-K on September 10, 2007 (the “September 10th Form 8-K”) in which the Company furnished slides to be presented at the Bear Stearns 20th Annual Healthcare Conference on September 10, 2007.  The Company is filing this amendment to the September 10th Form 8-K to revise two slides furnished in the September 10th Form 8-K.  The two revised slides are furnished as Exhibit 99.1 to this amendment to the September 10th Form 8-K.

This excerpt taken from the MDCO 8-K filed Sep 10, 2007.

Item 7.01.  Regulation FD Disclosure.

The Medicines Company (the “Company”) plans to make a company presentation at the Bear Stearns 20th Annual Healthcare Conference on September 10, 2007.  The slides that the Company will present are furnished as Exhibit 99.1 to this Current Report on Form 8-K.

This excerpt taken from the MDCO 8-K filed Jul 2, 2007.

Item 7.01.  Regulation FD Disclosure.

On July 2, 2007, The Medicines Company (the “Company”) reported that the Company has submitted a new drug application (“NDA”) for Cleviprex™ (clevidipine) to the Food and Drug Administration.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

THE MEDICINES COMPANY

 

 

 

 

 

 

 

Date:  July 2, 2007

By:

/s/ Paul M. Antinori

 

 

 

 

Paul M. Antinori

 

 

 

 

Senior Vice President and General Counsel

 



Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki